IGM Biosciences Inc (IGMS)
10.07
+0.64
(+6.79%)
USD |
NASDAQ |
May 03, 16:00
10.03
-0.04
(-0.40%)
After-Hours: 20:00
IGM Biosciences Total Liabilities (Quarterly): 220.18M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 220.18M |
| September 30, 2023 | 220.49M |
| June 30, 2023 | 222.05M |
| March 31, 2023 | 223.31M |
| December 31, 2022 | 226.24M |
| September 30, 2022 | 212.76M |
| June 30, 2022 | 206.79M |
| March 31, 2022 | 53.22M |
| December 31, 2021 | 53.22M |
| September 30, 2021 | 46.65M |
| Date | Value |
|---|---|
| June 30, 2021 | 28.21M |
| March 31, 2021 | 24.86M |
| December 31, 2020 | 26.82M |
| September 30, 2020 | 23.54M |
| June 30, 2020 | 22.10M |
| March 31, 2020 | 19.14M |
| December 31, 2019 | 21.12M |
| September 30, 2019 | 15.23M |
| June 30, 2019 | 6.701M |
| December 31, 2018 | 69.81M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
6.701M
Minimum
Jun 2019
226.24M
Maximum
Dec 2022
98.56M
Average
46.65M
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
| Inotiv Inc | 581.35M |
| Synlogic Inc | 32.90M |
| BioXcel Therapeutics Inc | 130.21M |
| Xilio Therapeutics Inc | 24.10M |
| NovaBay Pharmaceuticals Inc | 5.72M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 423.41M |
| Shareholders Equity (Quarterly) | 203.23M |
| Current Ratio | 8.182 |